NCT02793687 - Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

March 6, 2015

Primary Completion Date

May 27, 2016

Study Completion Date

May 27, 2016

Conditions

Ischemic Stroke

Interventions

DRUG

Mexidol

50 mg/ml IV solution, 125 mg tablet

OTHER

Placebo

Placebo IV solution, Placebo tablet

Trial Locations (11)

Vsevolozhsk Clinical Interdistrict Hospital, Vsevolozhsk

St. Petersburg Clinical Hospital № 26, Saint Petersburg

St. Petersburg Clinical Hospital № 2, Saint Petersburg

City Hospital № 40 of Kurortny District, Sestroretsk

"St. Petersburg Nikolaevskaya Hospital", Saint Petersburg

Tatarstan Republican Clinical Hospital, Kazan'

Interregional Clinical Diagnostic Center, Kazan'

Kazan Clinical Hospital № 7, Kazan'

Samara Regional Clinical Hospital n.a. V. D. Seredavin, Samara

Samara Clinical Hospital № 1 n.a. N. I. Pirogov, Samara

Research Institute of Experimental and Clinical Medicine, Novosibirsk